Items in cart [0] Questions? Call 888-624-8373

Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters Display this book on your site! Related Titles Catalyzing Inquiry at the Interface of Computing and Biology Reaping the Benefits of Genomic and Proteomic Research: Intellectual Property Rights, Innovation, and Public Health Other Related Titles Defining the Mandate of Proteomics in the Post-Genomics Era: Workshop Report (2002) Board on International Scientific Organizations (BISO) Board on Life Sciences (BLS) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 40   E-mail  Facebook  Digg  Stumble  Twitter More Page 40 Front Matter (R1-R11) Workshop Report (1-30) References (31-31) Appendix A: Speaker Biographies (32-35) Appendix B: Symposium Agenda (36-39) Appendix C: Workshop Participants (40-44)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 40
APPENDIX C WORKSHOP PARTTCIPANTS Ruedi Aebersold, University of Washington Mayada Akil, National Institutes of Health N. Leigh Anderson, Large Scale Biology Corporation Norman Anderson, Large Scale Biology Corporation Phi! Andrews,University of Michigan Wilhelm Ansorge, European Molecular Biology Laboratory Ettore Appella, National Cancer Institute Rolf Apweiler, European Bioinformatics Institute Cheryl Arrowsmith, University of Toronto Patsy Babbitt, University of California, San Francisco Thomas Baldwin, University of Arizona Michael Baldwin, University of California, San Francisco Mary Joy Ballantyne, Institute of Medicine Rudy Baum, Chemical & Engineering News Walter Blackstock, Celizome AG Steve Those, Bio-Rad Laboratories, Inc. Ralph Bradshaw, University of California, Irvine Thomas Brady, IBM Life Sciences Solutions Steven Brown, University of Delaware Gregory Brown, Adams, Harkness & Hill, Tnc. Eugene Bruce, National Science Foundation Alma Burlingame, University of California, San Francisco Allen Bush, University of Maryland-Baltimore Malcolm Byrnes, Howard University College of Medicine Dolores Cahill, Max-Planck Institute of Molecular Genetics Gerald CarIson, University of Missouri-Kansas City Donald Carison, University of California, Davis Marvin Cassman, National Institute of General Medical Sciences Julio Cells, Institute for Cancer Biology and Danish Centre for Human Genome Research Ron Cerny, University of Nebraska-Lincoin Brian Chait, The Rockefeller University Donald Chambers, University of Illinois at Chicago Kathy Champion, Genentech, Inc. Parag Chitnis, National Science Foundation Brian Clark, University of Aarhus Eleazar Cohen, National Institutes of Health Rhonna Cohen, University of Illinois at Chicago Dean Cole, U.S. Department of Energy Roberta Coleman, University of Delaware Patrick Coleman, 3M Company C-]

OCR for page 41
Francis Collins, National Human Genome Research Institute Christine Colvis, National Institutes of Health Marguente Coomes, Howard University College of Medicine Ben Cravett, Scripps Research Institute Michael Cusanovich, University of Arizona Matthew Davison, Aventis Pharmaceuticals Alison Deckhut, National Institutes of Health David DeMarini, U.S. Environmental Protection Agency Longwen Deng, George Washington University Medical School Edward Dennis, University of California, San Diego Robert Eades, IBM Life Sciences Solutions Charles Edmonds, National Institute of General Medical Sciences Jonathan Epstein, National Institutes of Health Adam Felsenfeld, National Human Genome Research Institute Madalyn Freund, GeneProt, Inc. Felix Friedberg, Howard University Medical School Bruce Futcher, SUNY at Stony Brook Tom Gadek, Genentech, Inc. David Galas, Keck Graduate Institute of Applied Life Sciences Daniel Gallahan, National Cancer Institute Pamela Gamble, National Research Council Donita Garland, National Eye Institute Hellen Gelband, Institute of Medicine John Gerit, University of Illinois Misrak Gezmu, National Institutes of Health Bradford Gibson, Buck Institute of Age Research Maria Giovanni, National Institutes of Health Gary Giulian, National Institutes of Health Allan Goldstein, George Washington University Medical Center Andrew Gooley, Proteome Systems, Ltd. David Gorenstein, University of Texas Medical Branch Judith Greenberg, National Institutes of Health lack Greenblatt, University of Toronto Marvin Hackert, University of Texas at Austin William Hancock, Journal of Proteome Research Eva Harris, University of California, Berkeley Gerald Hart, John Hopkins School of Medicine Richard Helm, Virginia Tech Preston Hensley, Pfizer John Hobbs, Beckman Coulter, Inc. Denis Hochstrasser, University of Geneva Scott Hutton, ChemNavigator Richard Ikeda, National Institutes of Health Warren Jones, National Institutes of Health Robert Kaiser, Prolinx, Inc. Thea Kalebic, National Cancer Institute C-2

OCR for page 42
Izet Kapetanovic, National Cancer Institute km Karam, Tulane University Arthur Katz, U.S. DeparLnent of Energy Peter Kennelly, Virginia Tech George Kenyon, University of Michigan Jack Kirsch, University of California, Berkeley Mark Knepper, National Heart, Lung & Blood Institute John Kozarich, Activx Biosciences Joshua LaBaer, Harvard Medical School Linda Lambert, National Institutes of Health David Lamb eth, Emory University Medical School Frank Laukien, Bruker Daltonics Claude Lenfant, National Heart, Lung & Blood Institute William Lennarz, SUNY at Stony Brook Thomas Leyh, Albert Einstein College of Medicine Mary Lopez, Proteome Systems Ltd. Anthony Macaluso, National Institute of Allergy & Infectious Disease Anil MadJukuri, George Washington University Edward Maggio, Structural Bioinformatics Inc. Nina Mani, Institute of Medicine Kenneth Mann, University of Vermont Joel Martin, Forward Ventures Stephen Martin, Applied Biosystems David Martin, Jr., EOS Biotechnology, Inc. Hiroyuki Matsumoto, University of Oklahoma Health Sciences Center Gerald McLaughlin, National Institutes of Health Djamel Me~jahed, National Cancer Institute Noelle Metting, U.S. Department of Energy Steve Michnick, Universite de Montreal Darren Monchkton, The University of Glasgow Walter Moos, Mitokor Richard Moms, National Institutes of Health James Myers, Pacific Northwest National Laboratory Kenneth Neet, Finch UHS/Chicago Medical School Robert Negm, National Cancer Institute Karoly Nikolich, AGY Therapeutics James Nolan, Tulane University, School of Medicine John Norvell, National Institutes of Health Susan O1d, National Heart, Lung & Blood Institute Jong Park, Medical Research Council Scott Patterson, Celera Genomics Cloud Paweletz, U.S. Food and Drug Administration Rainer Pepperkok, EMBE Heidelbrg Gregory Petsko, Brandeis University Patricia Powell, National Institutes of Health Thierry Rabilloud, CNRS C-3

OCR for page 43
.- Kal Ramnarayan, Structural Bioinformatics, Inc. Urs Regenass, Discovery Partners International Allen Rhoads, Howard University, College of Medicine Tim Riley, Micromass, Inc. Dagmar Ringe, Brandeis University Gerald Rubin, Howard Hughes Medical Institute M. Ruffin, Biotechnology Industry Organization James Ryan, American Chemical Society Alan Sachs, Merck Research Laboratory Andrej Sali, Rockefeller University SalvaTore Sechi, National Institutes of Health Opendra Shanna, National Institutes of Health Laura Sheahan, National Research Council Douglas Sheeley, National Institutes of Health Marilee Shelton, National Research Council Ben Shen, Genentech, Inc. Miho Shimizu, Johns Hopkins University Michael Silber, Pfizer Kimmen Sjolander, University of California, Berkeley Thomas Smith, Howard University Sylvia Spengler, National Science Foundation Christopher Spivey, Human Proteome Organisation Su~hir Srivastava, National Cancer Institute Ken Standing, University of Manitoba Robert Star, National Institutes of Health Gordon Strachan, University of Pennsylvania John Stults, Genentech, Inc. Hisaaki Taniguchi, Harima Institute at SPring-8 David Thomassen, U.S. Department of Energy David U'Prichard, 3-Dimensional Pharmaceuticals Jesus Valenzuela, National Institutes of Health Ruth Van Bogelen, Pfizer Alain Van Dorsselaer, Louis Pasteur University & CARS Thomas Vanaman, University of Kentucky Medical Center Thomas Vanaman, University of Kentucky Akos Vertes, George Washington University Marvin Vestal, Applied Biosystems Marc Vidal, Dana-Farber Cancer Institute Richard Wagner, Phylos, Inc. John Walker, Medical Research Council, Cambridge UK Wendy Wang, National Cancer Institute Scott Warder, Abbott Laboratories Mary Warner, American Chemical Society Scott Weidman, National Research Council Robert Wells, Texas A&M University Richard Whitehead, Otsuka Maryland Research Institute C-4

OCR for page 44
John Wiktorkowicz, Lynx Therapeutics, Inc. Richard Wolfenden, University of North Carolina James Wong, Beckman Coulter, Inc. Tamae Wong, National Research Council C-5

Representative terms from entire chapter:

blood institute